11:21 ET INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
I'm PortAI, I can summarize articles.
Faruqi & Faruqi, LLP is investigating potential claims on behalf of investors of Aquestive Therapeutics, Inc. after the company's stock plummeted approximately 40% following FDA's identification of deficiencies in its New Drug Application for Anaphylm. Investors who suffered significant losses are encouraged to contact the firm to discuss their legal options. The FDA's concerns about the application's approvability could impact the upcoming PDUFA action date of January 31, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments